Results 221 to 230 of about 264,021 (301)

Prophylactic transarterial chemoembolization after R0 resection is beneficial to improve the prognosis in hepatocellular carcinoma patients with microvascular invasion. [PDF]

Discov Oncol
Sun W, Li Y, Fu H, Li J, Li J.
europepmc   +1 more source

Pattern‐Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Aberrant p53 expression may have prognostic significance in colorectal cancer; however, its role in patients with colorectal liver metastases (CRLM) who receive neoadjuvant chemotherapy but do not achieve pathological complete response (pCR) remains unclear.
Phat Thi Hong Ho, Duy Duc Nguyen, Vuong Dinh Thy Hao, Giang Huong Tran, Lam Viet Trung, Thinh Van Hoang, Hoang Bac Nguyen   +6 more
wiley   +1 more source

Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Pathologic complete response (pCR), which reflects the local immune status and preoperative chemotherapy efficacy, has garnered significant attention in gastric cancer research. However, the predictive value of peripheral lymphocyte subsets for pCR in gastric cancer patients receiving preoperative chemotherapy remains unclear.
Zirui Xue, Dan Liu, Zhaodong Sun, Bosen Li, Xinyou Liu, Junjie Zhao, Haojie Li, Xuefei Wang, Zhaoming Wang   +8 more
wiley   +1 more source

Adjuvant radiation therapy is not associated with a survival benefit after R0 resection in non-metastatic adrenocortical carcinoma. [PDF]

Am J Surg
Greenspun BC, Lee-Saxton YJ, Egan CE, Marshall TE, Tumati A, Pearson B, Beninato T, Zarnegar R, Fahey TJ, Finnerty BM.   +9 more
europepmc   +1 more source

Breast Modular Resection Surgery Teaching Model Improves the Effect of Teaching Under Regional Anesthesia for Breast Conserving Surgery and Sentinel Lymph Node Biopsy in Day Surgery

Health Care Science, Volume 5, Issue 5, Page 461-472, October 2026.
This study validates a novel Breast Modular Resection (BMR) teaching model for breast‐conserving surgery under regional anesthesia. The BMR approach significantly improves surgical proficiency, reduces re‐excision rates and pain, and facilitates safe day‐case discharge with superior cosmetic outcomes. ABSTRACT Background Breast‐conserving surgery (BCS)
Ru Yao, Aocheng Wu, Jie Lian, Linjuan Tan, Lu Gao, Bo Pan, Qiang Sun, Yidong Zhou   +7 more
wiley   +1 more source

Correction to: R0 resection of linitis plastica of the stomach with synchronous bilateral Krukenberg tumours in a young woman. [PDF]

J Surg Case Rep
europepmc   +1 more source

Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort study. [PDF]

Jpn J Clin Oncol
Iyoshi S, Sunohara M, Yoshihara M, Kunishima A, Miyamoto E, Fujimoto H, Kitami K, Mogi K, Uno K, Yoshida K, Tamauchi S, Yokoi A, Niimi K, Yoshikawa N, Emoto R, Matsui S, Kajiyama H.   +16 more
europepmc   +1 more source

α2,3‐Sialyltransferase (ST3Gal1) regulates endometrioid‐type epithelial ovarian cancer cell migration and invasion via VEGF‐R2/JAK2/STAT3 signaling cascades

International Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 453-465, October 2026.
Abstract Objective To investigate the role of ST3 β‐galactoside α‐2,3‐sialyltransferase 1 (ST3Gal1) and vascular endothelial growth factor receptor 2 (VEGF‐R2) in endometrioid‐type epithelial ovarian cancer (E‐OC) because aberrant α2,3‐sialylation mediated by ST3Gal1 and VEGF‐R2‐related angiogenesis is linked with tumor progression. Methods ST3Gal1 and
Wei‐Ting Chao, Chia‐Hao Liu, Szu‐Ting Yang, Chen‐Hao Lin, Liang‐Wei Wang, Peng‐Hui Wang   +5 more
wiley   +1 more source

Case report: a R0 resection successfully induced by T-DXd plus PD-1 inhibitor regimen in a primary unresectable stage IIIB NSCLC with ERBB2-mutation. [PDF]

NPJ Precis Oncol
Zhang R, Cheng S, Sun K, Zhang L, Yan X, Yang F.   +5 more
europepmc   +1 more source

Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma

Journal of Surgical Oncology, Volume 134, Issue 5, Page 631-638, October 2026.
ABSTRACT Introduction Neoadjuvant therapy for pancreatic adenocarcinoma (PDAC) has evolved from single‐agent to multi‐agent approaches, largely informed by metastatic disease studies demonstrating improved survival; albeit at the price of increased toxicity. It remains unclear how response to varied neoadjuvant regimens impact survival. We hypothesized
Mohammed O. Suraju, Brian Longbottom, Jasmine A. Peterson, Terry Hayes, Kiers Brevik, Sean Y. Kim, Paolo Goffredo, Imran Hassan, Hassan Aziz, Carlos H. F. Chan   +9 more
wiley   +1 more source